Defining SARS-CoV-2 Bivalent Vaccines and Optimizing Protection Through Vaccination
Wendy Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP; Jacinda Abdul-Mutakabbir, PharmD; and Rodney E. Rohde, PhD, MS, SM(ASCP)CM, SVCM, MBCM, FACSc; review what encompasses a bivalent vaccine and give their perspective on how to communicate the role of the vaccine in optimizing protection for patients.
EP: 1.Overview of SARS-CoV-2 Virus and Subvariants
EP: 2.Defining Variants of Interest vs Variants of Concern
EP: 3.Impact of SARS-CoV-2 Subvariants on Vaccination
EP: 4.COVID-19 Booster Vaccination Protection Rates
EP: 5.Evolution of SARS-CoV-2 Variants on Booster Shot Development and Formulations
Now Viewing
EP: 6.Defining SARS-CoV-2 Bivalent Vaccines and Optimizing Protection Through Vaccination
EP: 7.CDC and FDA Recommendations for SARS-CoV-2 Booster Shots
EP: 8.Influenza Vaccination With SARS-CoV-2 mRNA Booster Shots
EP: 9.Long-Term Data on SARS-CoV-2 Booster Shots
EP: 10.Initiating Patient Conversations Around SARS-CoV-2 Booster Shots
EP: 11.Safety of SARS-CoV-2 Bivalent Booster Shots
EP: 12.Impact of COVID-19 Pandemic on Antimicrobial Resistance
EP: 13.Addressing Vaccine Hesitancy and Uptake for SARS-CoV-2
Related Videos
Related Content
